↗
investz
Investing, A to Z
Markets
News
Research
Screener
Sectors
Learn
Watchlists
Portfolio
Books
Audio
☀
S&P 500 · SPY
759.97
▼ -3.99 (-0.52%)
DOW JONES · DIA
521.37
▼ -6.52 (-1.24%)
NASDAQ · QQQ
704.40
▼ -0.07 (-0.01%)
GOLD · GLD
$366.61
▼ -2.39 (-0.65%)
OIL (WTI) · USO
$169.53
▲ +7.02 (+4.32%)
BITCOIN
$80,260.17
▼ -1,421.62 (-1.74%)
--:--:--
NYSE · Live ET
ALLO (ALLO)
1.25
0.00 (0.00%)
USD · · delayed · updates about every minute
☆ Add to watchlist
Key statistics
Previous close
1.25
Day range
1.16 – 1.26
52-week low
1.04
52-week high
4.46
Volume
—
Type
—
52-WEEK RANGE POSITION
ALLO news
Investing.com Australia
Form 4 Allogene Therapeutics Inc: Geoffrey M. Parker (CFO) For: 21 October
8h ago
Investing.com
Allogene Therapeutics CFO Geoffrey Parker sells $48,698 in stock
9h ago
TradingView
Allogene Therapeutics, Inc. Estimates – NASDAQ:ALLO
16h ago
Stock Titan
To cover vesting-related taxes, Allogene Therapeutics (ALLO) CFO sells 36,342 shares.
18h ago
Yahoo Finance
Tikva Allocell Selected to Present Preclinical CD19.SB9.CAR-EBVST Data at ACR Convergence 2026
2d ago
Investing.com UK
Form 144 Allogene Therapeutics For: 21 October By Investing.com
3d ago
Stock Titan
An officer proposes selling 36,342 Allogene Therapeutics (NASDAQ: ALLO) shares after stock vesting.
3d ago
Yahoo Finance
GOA Therapeutics Launches $300 Million Stock Offerings to Advance First in Class Drug Candidate for Acute Alcohol Intoxication
4d ago
Learn to invest
The Psychology of Money
Morgan Housel ·
Beginner
The Little Book of Common Sense Investing
John C. Bogle ·
Beginner
The Intelligent Investor
Benjamin Graham ·
Intermediate